These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
220 related articles for article (PubMed ID: 23452668)
21. Daily granulocyte and monocyte adsorptive apheresis in patients with active ulcerative colitis: a prospective safety and feasibility study. Yamamoto T; Umegae S; Matsumoto K J Gastroenterol; 2011 Aug; 46(8):1003-9. PubMed ID: 21681409 [TBL] [Abstract][Full Text] [Related]
22. Granulocyte/monocyte adsorptive apheresis for the treatment of therapy-refractory chronic active ulcerative colitis. Dignass A; Akbar A; Baumgart DC; Bommelaer G; Bouguen G; Cadiot G; Gillessen A; Grimaud JC; Hart A; Hoque S; Makins R; Michiels C; Moreau J; Premchand P; Ramlow W; Schanz S; Subramanian S; von Tirpitz C; Bonaz B Scand J Gastroenterol; 2018 Apr; 53(4):442-448. PubMed ID: 29513111 [TBL] [Abstract][Full Text] [Related]
23. Long-term clinical impact of early introduction of granulocyte and monocyte adsorptive apheresis in new onset, moderately active, extensive ulcerative colitis. Yamamoto T; Umegae S; Matsumoto K J Crohns Colitis; 2012 Aug; 6(7):750-5. PubMed ID: 22398094 [TBL] [Abstract][Full Text] [Related]
24. Adsorptive Depletion of Myeloid Lineage Leucocytes as Remission Induction Therapy in Patients with Ulcerative Colitis after Failure of First-Line Medications: Results from a Three-Year Real World, Clinical Practice. Iida T; Ikeya K; Kato M; Abe J; Yamamoto M; Watanabe F; Sugimoto K; Hanai H Digestion; 2017; 96(2):119-126. PubMed ID: 28796990 [TBL] [Abstract][Full Text] [Related]
25. Factors associated with the outcomes in ulcerative colitis patients undergoing granulocyte and monocyte adsorptive apheresis as remission induction therapy: A multicenter cohort study. Ishiguro Y; Ohmori T; Umemura K; Iizuka M Ther Apher Dial; 2021 Aug; 25(4):502-512. PubMed ID: 33029920 [TBL] [Abstract][Full Text] [Related]
26. Relevance of the processed blood volume per granulocyte and monocyte apheresis session to its clinical efficacy in patients with ulcerative colitis. Kikuyama R; Fukunaga K; Kawai M; Yokoyama Y; Kamikozuru K; Hida N; Ohda Y; Takeda N; Yoshida K; Iimuro M; Kato K; Kono T; Nogami K; Nagase K; Nakamura S; Takei Y; Miwa H; Matsumoto T Ther Apher Dial; 2011 Aug; 15(4):360-6. PubMed ID: 21884470 [TBL] [Abstract][Full Text] [Related]
27. Efficacy of cytapheresis for remission induction and dermatological manifestations of ulcerative colitis. Nomura O; Osada T; Shibuya T; Ishikawa D; Haga K; Kodani T; Sakamoto N; Ogihara T; Yamaji K; Watanabe S J Clin Apher; 2018 Feb; 33(1):21-28. PubMed ID: 28581039 [TBL] [Abstract][Full Text] [Related]
28. Treatment cost of ulcerative colitis is apheresis with Adacolumn cost-effective? Panés J; Guilera M; Ginard D; Hinojosa J; González-Carro P; González-Lara V; Varea V; Domènech E; Badia X Dig Liver Dis; 2007 Jul; 39(7):617-25. PubMed ID: 17531555 [TBL] [Abstract][Full Text] [Related]
29. Adacolumn selective leukocyte adsorption apheresis in patients with active ulcerative colitis: clinical efficacy, effects on plasma IL-8, and expression of Toll-like receptor 2 on granulocytes. Aoki H; Nakamura K; Yoshimatsu Y; Tsuda Y; Irie M; Fukuda K; Hosoe N; Takada N; Shirai K; Suzuki Y Dig Dis Sci; 2007 Jun; 52(6):1427-33. PubMed ID: 17394078 [TBL] [Abstract][Full Text] [Related]
30. Selective granulocyte-monocyte apheresis during induction with vedolizumab in moderate-severe ulcerative colitis: Experience in a tertiary hospital. Suárez Ferrer C; Martin-Arranz E; Martín-Arranz MD Gastroenterol Hepatol; 2024; 47(7):721-726. PubMed ID: 38219961 [TBL] [Abstract][Full Text] [Related]
31. Combined effects of granulocyte and monocyte adsorption apheresis and corticosteroids on ulcerative colitis. Tsuzuki Y; Shiomi R; Matsumoto H; Miyaguchi K; Kusano T; Ohgo H; Nakamoto H; Imaeda H J Clin Biochem Nutr; 2023 Jan; 72(1):68-73. PubMed ID: 36777077 [TBL] [Abstract][Full Text] [Related]
32. Clinical response is associated with elevated plasma interleukin-1 receptor antagonist during selective granulocyte and monocyte apheresis in patients with ulcerative colitis. Sakimura K; Omori T; Iwashita E; Yoshida T; Tsuzuki Y; Fujimori K; Konishi F; Yoshida Y; Anzai H; Suzuki H; Sugawara S; Takeda Y; Hiraishi K; Saniabadi AR; Ide T; Miura S; Ota S Dig Dis Sci; 2006 Sep; 51(9):1525-31. PubMed ID: 16902810 [TBL] [Abstract][Full Text] [Related]
33. Intermittent granulocyte and monocyte apheresis versus mercaptopurine for maintaining remission of ulcerative colitis: a pilot study. Sakuraba A; Sato T; Morohoshi Y; Matsuoka K; Okamoto S; Inoue N; Takaishi H; Ogata H; Iwao Y; Hibi T Ther Apher Dial; 2012 Jun; 16(3):213-8. PubMed ID: 22607563 [TBL] [Abstract][Full Text] [Related]
34. Safety and Efficacy of Granulocyte/Monocyte Apheresis in Steroid-Dependent Active Ulcerative Colitis with Insufficient Response or Intolerance to Immunosuppressants and/or Biologics [the ART Trial]: 12-week Interim Results. Dignass A; Akbar A; Hart A; Subramanian S; Bommelaer G; Baumgart DC; Grimaud JC; Cadiot G; Makins R; Hoque S; Bouguen G; Bonaz B J Crohns Colitis; 2016 Jul; 10(7):812-20. PubMed ID: 26818659 [TBL] [Abstract][Full Text] [Related]
35. A pilot open-labeled prospective randomized study between weekly and intensive treatment of granulocyte and monocyte adsorption apheresis for active ulcerative colitis. Sakuraba A; Sato T; Naganuma M; Morohoshi Y; Matsuoka K; Inoue N; Takaishi H; Ogata H; Iwao Y; Hibi T J Gastroenterol; 2008; 43(1):51-6. PubMed ID: 18297436 [TBL] [Abstract][Full Text] [Related]
36. Concomitant pharmacologic medications influence the clinical outcomes of granulocyte and monocyte adsorptive apheresis in patients with ulcerative colitis: A multicenter retrospective cohort study. Ueno N; Sugiyama Y; Kobayashi Y; Murakami Y; Iwama T; Sasaki T; Kunogi T; Sakatani A; Takahashi K; Tanaka K; Serikawa S; Ando K; Kashima S; Muto M; Inaba Y; Moriichi K; Tanabe H; Okumura T; Fujiya M J Clin Apher; 2023 Aug; 38(4):406-421. PubMed ID: 36636880 [TBL] [Abstract][Full Text] [Related]
37. Adsorptive granulocyte/monocyte apheresis for the maintenance of remission in patients with ulcerative colitis: a prospective randomized, double blind, sham-controlled clinical trial. Fukunaga K; Yokoyama Y; Kamokozuru K; Nagase K; Nakamura S; Miwa H; Matsumoto T Gut Liver; 2012 Oct; 6(4):427-33. PubMed ID: 23170145 [TBL] [Abstract][Full Text] [Related]
38. Adacolumn leucocytapheresis for ulcerative colitis: clinical and endoscopic features of responders and unresponders. Sacco R; Tanaka T; Yamamoto T; Bresci G; Saniabadi AR Expert Rev Gastroenterol Hepatol; 2015 Mar; 9(3):327-33. PubMed ID: 25160857 [TBL] [Abstract][Full Text] [Related]
39. Leukocytapheresis therapy for steroid-naïve patients with active ulcerative colitis: its clinical efficacy and adverse effects compared with those of conventional steroid therapy. Nishioka C; Aoyama N; Maekawa S; Shirasaka D; Nakahara T; Tamura T; Fukagawa M; Umezu M; Abe T; Kasuga M J Gastroenterol Hepatol; 2005 Oct; 20(10):1567-71. PubMed ID: 16174075 [TBL] [Abstract][Full Text] [Related]
40. An open-label prospective randomized multicenter study of intensive versus weekly granulocyte and monocyte apheresis in active crohn's disease. Yoshimura N; Yokoyama Y; Matsuoka K; Takahashi H; Iwakiri R; Yamamoto T; Nakagawa T; Fukuchi T; Motoya S; Kunisaki R; Kato S; Hirai F; Ishiguro Y; Tanida S; Hiraoka S; Mitsuyama K; Ishihara S; Tanaka S; Otaka M; Osada T; Kagaya T; Suzuki Y; Nakase H; Hanai H; Watanabe K; Kashiwagi N; Hibi T BMC Gastroenterol; 2015 Nov; 15():163. PubMed ID: 26585569 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]